Scientists in India have developed a new type of paper-based test for COVID-19 capable of giving results similar to that of a pregnancy test. The test based on a gene-editing technology called Crispr just cost around Rs 500 or BD2.57 based on Monday's transaction rates. Scientist
Scientists in India have developed a new type of paper-based test for COVID-19 capable of giving results similar to that of a pregnancy test.
The test based on a gene-editing technology called Crispr just cost around Rs 500 or BD2.57 based on Monday's transaction rates.
Scientists at the Delhi-based CSIR-Institute of Genomics and Integrative Biology (IGIB) who developed the test have named it after a fictional detective character Feluda.
Reports say Feluda made by Tata will be world’s first paper-based COVID-19 test available in the market.
"This is a simple, precise, reliable, scalable and frugal test," a BBC report quoted Professor K Vijay Raghavan, principal scientific adviser to the Indian government, as saying.
With more than six million confirmed infections, India has the world's second-highest Covid-19 caseload. After a slow start, BBC says, India is now testing more than a million samples a day in more than 1,200 laboratories across the country.
